Head of Oncology Research, Division of Therapeutics Discovery & Development; Executive Director, Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, The University of Texas MD Anderson Cancer Center, Houston.
Timothy P. Heffernan, Ph.D. is head of oncology research within the division of therapeutics discovery and development at The University of Texas MD Anderson Cancer Center in Houston.
Dr. Heffernan also serves as executive director for the Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) platform, a translational research unit focused on accelerating the pre-clinical evaluation of novel drugs to inform innovative clinical trials. His expertise lies in basic and translational cancer research, cancer genomics and targeted oncology therapeutics. Dr. Heffernan currently manages the development of an advanced drug discovery and development portfolio coordinating research on programs from target identification through phase 1 clinical development. Prior to joining MD Anderson, Dr. Heffernan led target identification efforts at the Belfer Institute at Dana Farber Cancer Institute. He also previously served as a senior vice president at C4 Therapeutics Inc., where he managed the drug discovery and translational biology efforts to advance a portfolio of internal and partnered programs.
Dr. Heffernan earned a doctor of philosophy degree in cell and molecular pathology from the University of North Carolina at Chapel Hill in Chapel Hill, N.C. and performed his postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School in Boston.